Novel antiviral fucoidan from sporophyll of Undaria pinnatifida (Mekabu)

Chem Pharm Bull (Tokyo). 2004 Sep;52(9):1091-4. doi: 10.1248/cpb.52.1091.

Abstract

Structural characterization and antiviral activities of fucoidan from sporophyll of Undaria pinnatifida (Mekabu) was examined. The fucoidan was composed of fucose and galactose with an approximately ratio of 1.0:1.1. Degree of substitution of sulfate was 0.72 and its apparent molecular weight was 9,000. Methylation analyses showed that fucoidan had various sugar linkages, and revealed that the fucoidan might have complicated structure. This fucoidan showed potent antiviral activities against herpes simplex virus type 1 (HSV-1), HSV-2, and human cytomegalovirus.

MeSH terms

  • Animals
  • Antiviral Agents / isolation & purification*
  • Antiviral Agents / pharmacology
  • Cell Line
  • Cytomegalovirus / drug effects
  • Enterovirus / drug effects
  • Herpesvirus 1, Human / drug effects
  • Herpesvirus 2, Human / drug effects
  • Influenza A virus / drug effects
  • Inhibitory Concentration 50
  • Poliovirus / drug effects
  • Polysaccharides / isolation & purification*
  • Polysaccharides / pharmacology
  • Undaria / chemistry*

Substances

  • Antiviral Agents
  • Polysaccharides
  • fucoidan